Michel Khalaf - MetLife President, Chief Executive Officer, Director
| MET Stock | USD 82.54 0.34 0.41% |
CEO
Mr. Michel A. Khalaf is President, Chief Executive Officer of MetLife, Inc., effective May 1, 2019. He joined MetLife as a result of the Acquisition. Mr. Khalaf served as Executive Vice President of MLIC from January 2011 until November 2011, and was Regional President, Middle East, Africa and South Asia of American Life from January 2009 until November 2011. Prior to the Acquisition, Mr. Khalaf had been deputy president and chief operating officer of Philamlife, the operating company of AIG in the Philippines, from August 2006 to October 2008. Mr. Khalaf has also held a number of leadership roles with ALICO in various markets around the world, including Poland, Egypt, Italy, France, and the Caribbean. since 2019.
| Age | 61 |
| Tenure | 6 years |
| Address | 200 Park Avenue, New York, NY, United States, 10166-0188 |
| Phone | 212 578 9500 |
| Web | https://www.metlife.com |
MetLife Management Efficiency
Return On Equity is likely to gain to 0.17 in 2025, whereas Return On Tangible Assets are likely to drop 0 in 2025. Change To Liabilities is likely to gain to about 5.4 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.1 B in 2025. MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Bill Leavell | Globe Life | 57 | |
| Peter ODonnell | Unum Group | 53 | |
| Kenneth Matson | Globe Life | 53 | |
| Laura Prieskorn | Prudential PLC ADR | 52 | |
| Steven DiChiaro | Globe Life | 54 | |
| Eric Steigerwalt | Brighthouse Financial | 61 | |
| Eric Johnson | CNO Financial Group | 65 | |
| Roy Gori | Manulife Financial Corp | 54 | |
| Richard McKenney | Unum Group | 56 | |
| Timothy Arnold | Unum Group | 62 | |
| Steven Greer | Globe Life | 51 | |
| Craig CFA | Jackson Financial | 57 | |
| Jason Harvey | Globe Life | 52 | |
| Anil Wadhwani | Prudential PLC ADR | 57 | |
| Michael Simonds | Unum Group | 51 | |
| Laura Prieskorn | Jackson Financial | 57 | |
| Anil Wadhwani | Manulife Financial Corp | N/A | |
| Paul Lorentz | Manulife Financial Corp | N/A | |
| Michael Falcon | Prudential PLC ADR | 56 | |
| Gary Bhojwani | CNO Financial Group | 57 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0051 |
MetLife Leadership Team
Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Chief VP | ||
| Catherine Kinney, Independent Director | ||
| Randolph Clerihue, Chief Officer | ||
| Carlos Gutierrez, Independent Director | ||
| Michael Roberts, Executive Vice President Chief Marketing Officer | ||
| Pawan Verma, Executive Vice President, Chief Information Officer | ||
| Stephen Gauster, Senior Vice President Interim General Counsel | ||
| Ramy Tadros, Executive Vice President and President - U.S. Business | ||
| Michel Khalaf, President, Chief Executive Officer, Director | ||
| Shurawl Sibblies, Executive Officer | ||
| Bill Pappas, Executive Vice President Head of Global Technology and Operations | ||
| Diana McKenzie, Independent Director | ||
| Randy Stram, Senior Benefits | ||
| Cheryl Grise, Lead Independent Director | ||
| Susan MBA, Executive Officer | ||
| John Hall, Senior Relations | ||
| Robert Hubbard, Independent Chairman of the Board | ||
| William Kennard, Independent Director | ||
| Steven Goulart, Executive Vice President, Chief Investment Officer | ||
| Susan Podlogar, Chief Human Resource Officer, Executive Vice President | ||
| Robert Merck, Global MD | ||
| David Herzog, Independent Director | ||
| Cindy Pace, Global Chief Diversity and Inclusion Officer | ||
| Robin Gordon, Chief Data and Analytics Officer | ||
| William Moore, President Business | ||
| Esther Lee, Executive Vice President Global Chief Marketing Officer | ||
| Edward Kelly, Independent Director | ||
| Gerald Hassell, Independent Director | ||
| Oscar Schmidt, President of Latin America | ||
| Michael Farrell, Head EVP | ||
| Denise Morrison, Independent Director | ||
| Nuria Garcia, Head of EMEA | ||
| Monica Curtis, Executive Officer | ||
| Marlene Debel, Executive Vice President, Chief Risk Officer | ||
| Mark Weinberger, Independent Director | ||
| John McCallion, Chief Financial Officer, Executive Vice President | ||
| Kishore Ponnavolu, President - Asia Region | ||
| John CPA, Executive CFO |
MetLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0051 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 72 B | ||||
| Shares Outstanding | 681.23 M | ||||
| Shares Owned By Insiders | 16.69 % | ||||
| Shares Owned By Institutions | 75.77 % | ||||
| Number Of Shares Shorted | 6.8 M | ||||
| Price To Earning | 28.61 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MetLife Stock Analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.